Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TriSalus Life Sciences (TLSI) Long-Term Investments (2022 - 2023)

Historic Long-Term Investments for TriSalus Life Sciences (TLSI) over the last 2 years, with Q2 2023 value amounting to $12.1 million.

  • TriSalus Life Sciences' Long-Term Investments fell 9517.5% to $12.1 million in Q2 2023 from the same period last year, while for Jun 2023 it was $12.1 million, marking a year-over-year decrease of 9517.5%. This contributed to the annual value of $19.8 million for FY2022, which is N/A changed from last year.
  • TriSalus Life Sciences' Long-Term Investments amounted to $12.1 million in Q2 2023, which was down 9517.5% from $20.2 million recorded in Q1 2023.
  • In the past 5 years, TriSalus Life Sciences' Long-Term Investments ranged from a high of $251.0 million in Q3 2022 and a low of $12.1 million during Q2 2023